EDW Pharma

EDW Pharma is a private specialty pharmaceutical company headquartered in Parsippany, New Jersey. The company focuses on the development, acquisition, and commercialization of branded and generic pharmaceutical products, with a core emphasis on women's healthcare and anti-infective treatments. Its primary commercial asset is Vandazole (metronidazole vaginal gel 0.75%), which is indicated for the treatment of bacterial vaginosis in non-pregnant women. EDW Pharma operates with a lean business model, seeking to provide high-quality and affordable therapeutic options through strategic partnerships and efficient supply chain management. The company targets niche markets where it can provide significant value to patients and healthcare providers.